Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Sergey Zaets, MD, PhD, DSc, FAAC Director, Clinical Development & Medical Affairs, Novo Nordisk, Inc., Plainsboro, NJ Sergey Zaets received MD degree from Moscow Medical Institute and PhD and DSc degrees from Bakoulev Center for Cardiovascular Surgery (Moscow, Russia), and used to work as a pediatric cardiac surgeon until relocation to the USA in 1999. During the years 1999-2005, he performed research studies on red blood cell dysfunction in trauma-hemorrhagic shock, burn, gut ischemia, and pancreatitis at the UMDNJ – New Jersey Medical School. In 2005, Sergey Zaets joined Novo Nordisk Inc. as a researcher and investigated the role of coagulation Factor XIII in prevention of multiple organ dysfunction after experimental trauma-hemorrhagic shock, burn, gut ischemia, and cardio-pulmonary bypass. Since 2009, he is involved in clinical development of new recombinant factors to be in hemophilia and FXIII congenital deficiency. Research interests: coagulation disorders, trauma-hemorrhagic shock, sepsis, congenital heart defects. Sergey Zaets is an author of more than 240 publications.
Coagulation disorders, trauma-hemorrhagic shock, sepsis, congenital heart defects. Sergey Zaets is an author of more than 240 publications.